Prevalence of undiagnosed type-2-diabetes mellitus and impaired fasting glucose in German primary care: Data from the German metabolic and cardiovascular risk project (GEMCAS)

Experimental and Clinical Endocrinology and Diabetes

Volumn 116, Issue 1, 2008, Pages 18-25

  Hauner, H ^a,f   Hanisch, J ^b   Bramlage, P ^c   Steinhagen Thiessen, E ^d   Schunkert, H ^e   Jockel K H ^b   Wasem, J ^b   Moebus, S ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e UNIVERSITY OF LÜBECK   (Germany)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cardiovascular risk; Epidemiology; Impaired fasting glucose; Prevalence; Prevention

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR RISK; FAMILY HISTORY; FEMALE; GENERAL PRACTICE; GERMANY; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCREENING; SEX RATIO; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GERMANY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; RISK FACTORS;

EID: 39449099887     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-985359     Document Type: Article

References (37)

1. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 2005; 366: 1059-1062
2. Balkau B. The DECODE study. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe. Diabetes Metab 2000; 26: 282-286
3. Balkau B, Vernay M, Mhamdi L et al. The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study. Diabetes Metab 2003; 29: 526-532
4. Christensen JO, Sandbaek A, Lauritzen T, Borch-Johnsen K. Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithms. Diabetologia 2004; 47: 1566-1573
5. Danaei G, Lawes CM, Vander Hoorn S, Murray CJ, Ezzati M. Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet 2006; 368: 1651-1659
6. Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 2003; 26: 575-581
7. Franse LV, Di Bari M, Shorr RI et al. Type 2 diabetes in older well-functioning people: who is undiagnosed? Data from the health, aging, and body composition study. Diabetes Care 2001; 24: 2065-2070
8. Gaede P, Vedel P, Larsen N et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383-393
9. Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752
10. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-234
11. Harris MI, Eastman RC. Early detection of undiagnosed diabetes mellitus: a US perspective. Diabetes Metab Res Rev 2000; 16: 230-236
12. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7yr before clinical diagnosis. Diabetes Care 1992; 15: 815-819
13. Hauner H. Occurrence of diabetes mellitus in Germany. Dtsch Med Wochenschr 1998; 123: 777-782
14. Hauner H, Koster I, Ferber L von. Prevalence of diabetes mellitus in Germany 1998-2001. Secondary data analysis of a health insurance sample of the AOK in Hessen/KV in Hessen. Dtsch Med Wochenschr 2003; 128: 2632-2637
15. Isomaa B, Almgren P, Tuomi T et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-689
16. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28: 2289-2304
17. Krone W, Böhm M. Erhebung und Verbesserung der Behandlungssituation von Patienten mit Diabetes mellitus. Das DUTY-Register. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2004; 47: 540-546
18. Lakka HM, Laaksonen DE, Lakka TA et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716
19. Lawrence JM, Bennett P, Young A, Robinson AM. Screening for diabetes in general practice: cross sectional population study. BMJ 2001; 323: 548-551
20. Lehnert H, Wittchen HU, Pittrow D et al. Prevalence and pharmacotherapy of diabetes mellitus in primary care. Dtsch Med Wochenschr 2005; 130: 323-328
21. Lieberman LS. Dietary, evolutionary, and modernizing influences on the prevalence of type 2 diabetes. Annu Rev Nutr 2003; 23: 345-377
22. Lindstrom J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 2003; 26: 725-731
23. Löwel H, Stieber J, Koenig W et al. The diabetes-related risk of myocardial infarction in a southern German population: results of the MONICA Augsburg studies 1985-1994. Diab Stoffw 1999; 8: 11-21
24. MacAuley KA, Williams SM, Mann JI et al. Diagnosing insulin resistance in the general population. Diabetes Care 2001; 24: 460-464
25. Moebus S, Hanisch JU, Neuhäuser M et al. Assessing the Metabolic Syndrome according to NCEP ATP III in Germany: Feasibility of a two step approach in 1 550 randomly selected primary health care practices. GMS 2006; 4, Doc7 (20061009)
26. Pittrow D, Stalla GK, Zeiher AM et al. Prevalence, drug treatment and metabolic control of diabetes mellitus in primary care. Med Klin (Munich) 2006; 101: 635-644
27. Rathmann W, Haastert B, Icks A et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000; Diabetologia 2003; 46: 182-189
28. SAS9.1 In. Release 9.1 ed. Cary NC: SAS Institute Inc., 2005
29. Sattar N, Gaw A, Scherbakova O et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003; 108: 414-419
30. Scherbaum WA, Dicken HD, Verheyen F, Baehring T. Detection of a previously unrecognized type 2 diabetes using a risk questionnaire. Efficiency for general population screening. Dtsch Med Wochenschr 2006; 131: 2208-2212
31. Schulze J, Rothe U, Muller G, Kunath H. Improvement of care for diabetics using the care model from Saxony. Dtsch Med Wochenschr 2003; 128: 1161-1166
32. Thefeld W. Prevalence of diabetes mellitus in the adult German population. Gesundheitswesen 1999; 61, Spec No:S85-89
33. UKPDS. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-713
34. UKPDS. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853
35. Uusitupa M, Siitonen O, Aro A, Pyorala K. Prevalence of coronary heart disease, left ventricular failure and hypertension in middle-aged, newly diagnosed type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 1985; 28: 22-27
36. Wareham NJ, Griffin SJ. Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria. BMJ 2001; 322: 986-988
37. WHO. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation. Part 1: Diagnosis and classification of diabetes mellitus, 1999